Does Blue Cross Blue Shield of Illinois Cover Viagra?

The Short Answer: It Depends on Your Specific Plan

BCBSIL does not apply a single uniform policy to sildenafil or Viagra across every product it offers. Whether your plan pays anything at all comes down to three variables: the plan type (employer-sponsored, ACA marketplace, Medicare Advantage, Medicaid managed care), the specific formulary your plan uses, and whether your doctor can satisfy a prior authorization (PA) criteria.

Brand-name Viagra (sildenafil citrate 25 mg, 50 mg, 100 mg) lost patent exclusivity in the United States in 2017. Since then, generic sildenafil has become widely available and considerably cheaper. BCBSIL commercial plans are far more likely to cover generic sildenafil than brand Viagra. The FDA maintains a current list of approved generic sildenafil products [1].

Plan Type Is the First Gate

Employer-sponsored group plans administered by BCBSIL have the most flexibility. Many large-group plans include sildenafil on their formulary, though typically with a PA step. Small-group and ACA individual marketplace plans are much more restrictive. The Affordable Care Act's essential health benefits framework does not require coverage of erectile dysfunction medications [2], so most ACA-compliant BCBSIL marketplace plans exclude them entirely.

The Formulary Tier Determines Your Copay

When sildenafil does appear on a BCBSIL formulary, it most commonly lands on Tier 2 (preferred generic) with a copay of $10, $30 per 30-day supply, or Tier 3 (non-preferred generic) at $30, $60. Brand Viagra, if listed at all, typically sits on Tier 4 or Tier 5, where cost-sharing can reach $100 or more per fill even with coverage. Because formularies change each plan year, you should verify your 2024 formulary on the BCBSIL member portal or by calling the number printed on your insurance card.

What Is Sildenafil and Why Does Insurance Coverage Get Complicated?

Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor. It was originally developed as an antihypertensive agent and was repurposed after researchers observed its effect on penile erections. The FDA approved Viagra for erectile dysfunction in March 1998 [3]. A separate sildenafil product branded Revatio (20 mg tablets and oral suspension) is FDA-approved for pulmonary arterial hypertension (PAH) and is covered far more consistently by insurance, including BCBSIL plans, because PAH is a life-threatening condition rather than a quality-of-life indication [4].

The ED Indication vs. The PAH Indication

This distinction matters clinically and financially. When a physician writes a prescription with a diagnosis code of N52.x (male erectile dysfunction), many insurers trigger automatic exclusion or mandatory PA review. If that same physician writes sildenafil for I27.0 (primary pulmonary arterial hypertension), coverage is usually approved without additional hurdles. Off-label prescribing of Revatio-dose sildenafil for ED is sometimes attempted, but pharmacists and payers routinely flag this, and doing so dishonestly constitutes insurance fraud.

Clinical Efficacy: What the Evidence Shows

Sildenafil's efficacy for ED is well-established. A Cochrane systematic review of 82 randomized controlled trials (N=9,119 participants) found that PDE5 inhibitors including sildenafil produced a risk ratio of 2.49 for achieving successful intercourse compared to placebo (95% CI 2.09 to 2.97) [5]. The American Urological Association (AUA) guidelines on erectile dysfunction name oral PDE5 inhibitors as first-line pharmacological therapy [6].

How Blue Cross Blue Shield of Illinois Plan Types Handle Coverage

Employer-Sponsored PPO and HMO Plans

Large employer groups that self-insure use BCBSIL as a third-party administrator. These employers set their own benefit design. As a result, some self-funded plans cover sildenafil generously, some exclude it outright, and some require PA plus step therapy (trying a less expensive alternative first). Your Summary of Benefits and Coverage (SBC) document, which federal law requires your employer to provide annually, will state whether "sexual dysfunction medications" are an excluded benefit. If the SBC is ambiguous, BCBSIL's pharmacy benefit line can confirm coverage within minutes.

ACA Marketplace Plans (IlliniCare, Blue Choice, BlueCare Direct)

ACA marketplace plans sold by BCBSIL in Illinois follow the state and federal essential health benefits benchmark, which does not include ED medications. Expect exclusion on Bronze, Silver, Gold, and Platinum tier marketplace plans. One exception: if you have a grandfathered or grandmothered ACA plan that predates 2014, the benefit design may differ.

Medicare Advantage Plans (BCBSIL Medicare Advantage)

Federal law prohibits Medicare Part D from covering drugs used for "sexual or erectile dysfunction" under 42 U.S.C. § 1395w-102(e)(2)(A) [7]. BCBSIL Medicare Advantage plans follow this restriction. Some Medicare Advantage plans include supplemental over-the-counter benefits that could theoretically offset costs, but no BCBSIL Medicare Advantage plan covers prescription sildenafil for ED as of 2024.

Medicaid Managed Care in Illinois

Illinois Medicaid (managed by plans including Meridian, Molina, and CountyCare, all sometimes referred to under BCBSIL networks depending on region) does not cover PDE5 inhibitors for erectile dysfunction. The Illinois Department of Healthcare and Family Services (IDHFS) Preferred Drug List excludes sildenafil under the ED indication [8].

Prior Authorization: What BCBSIL Actually Requires

For plans that do cover sildenafil, prior authorization is nearly universal. The PA criteria BCBSIL commonly applies include:

• A confirmed diagnosis of erectile dysfunction documented in the medical record
• Absence of contraindications (concurrent nitrate therapy is an absolute contraindication per FDA labeling) [3]
• Prescriber attestation that the patient has been counseled on cardiovascular risk
• In some plan years, documentation that a trial of a Tier-2 agent was attempted (step therapy)

How to File a PA

Your prescribing physician or their office staff submits the PA to BCBSIL's pharmacy benefits department. You can also initiate this by calling the Member Services number on your card and requesting the specific form number. Under Illinois law (215 ILCS 5/155.22b), health insurers must provide a PA decision within 72 hours for urgent requests and within 15 calendar days for standard requests [9].

What to Do If PA Is Denied

Request a formal written denial that states the specific clinical reason. Your plan is required to provide this under the ACA [2]. You then have the right to an internal appeal and, if that fails, an external independent medical review. Illinois requires external review be completed within 45 days for standard appeals and 72 hours for expedited requests under 215 ILCS 5/155.22 [9].

The HealthRX PA Appeal Framework for Sildenafil Coverage:

1. Obtain the written denial with the denial code and clinical rationale.
2. Have your physician write a letter of medical necessity citing the AUA ED guidelines [6] and your specific cardiovascular evaluation findings.
3. If step therapy was the reason for denial, document any contraindications or past failures with the required prior drug.
4. Submit the internal appeal within the plan's stated deadline (usually 180 days from denial).
5. If internal appeal fails, file for Illinois external review through the Illinois Department of Insurance at doi.illinois.gov within four months of the final internal denial.

Real Costs: What You Will Pay With and Without BCBSIL Coverage

Understanding actual numbers helps set realistic expectations.

With BCBSIL Coverage (Sildenafil Generic, Tier 2)

A 30-day supply (6 tablets of sildenafil 100 mg, typically cut in half for 12 doses) may cost $10, $30 as your copay on a Tier-2 formulary placement. Annual cost: roughly $120, $360.

Without Coverage or on an Excluding Plan

Retail pharmacy prices for generic sildenafil vary significantly by chain. GoodRx pricing as of mid-2024 lists 6 tablets of sildenafil 100 mg between $14 and $35 at major Illinois pharmacies, depending on which coupon or discount program you use. Brand Viagra (6 x 100 mg tablets) runs $450, $700 at retail without any discount.

Telehealth and Cash-Pay Clinics

Several telehealth platforms (not affiliated with HealthRX) offer sildenafil through cash-pay models for $1, $3 per tablet when purchased in bulk, often without needing insurance. This may be the most cost-effective route for patients on ACA marketplace plans that exclude ED medications entirely.

Sildenafil vs. Other PDE5 Inhibitors: Does BCBSIL Treat Them Differently?

The four FDA-approved oral PDE5 inhibitors are sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra). Generic tadalafil has been available since 2018 and is also widely used. BCBSIL commercial plans that cover any PDE5 inhibitor typically include both generic sildenafil and generic tadalafil on Tier 2 or Tier 3.

Tadalafil as an Alternative

Tadalafil 5 mg daily is also FDA-approved for benign prostatic hyperplasia (BPH), diagnosis code N40.x. If you carry both an ED and a BPH diagnosis, your physician may prescribe tadalafil for BPH, and that indication often bypasses the ED exclusion. Discuss this option honestly with your doctor. A 2020 meta-analysis in the British Journal of Clinical Pharmacology (N=4,830) confirmed tadalafil 5 mg daily improved both BPH symptoms and erectile function compared to placebo [10].

Avanafil and Vardenafil Coverage

Avanafil (Stendra) and brand vardenafil (Levitra) remain branded and expensive. BCBSIL plans rarely place these on a preferred tier. Generic vardenafil entered the US market in 2019 but has not achieved the same formulary penetration as sildenafil or tadalafil.

When Sildenafil Is Prescribed for Pulmonary Arterial Hypertension

This section applies to patients who have both ED and PAH, or who are considering off-label use. Revatio (sildenafil 20 mg) is FDA-approved for PAH and is covered far more reliably by BCBSIL plans. The 2022 American College of Cardiology / American Heart Association joint guidelines on pulmonary hypertension designate sildenafil as a Class I, Level A recommendation for WHO Group 1 PAH [11]. For patients who genuinely have PAH, coverage denial is unusual and legally more challengeable.

Using a PAH diagnosis to obtain coverage for sildenafil in the absence of PAH is fraudulent. It also carries real medical risk: sildenafil doses for PAH (60 mg daily) differ from ED doses (25 to 100 mg as needed) and could result in inappropriate dosing.

Practical Steps to Confirm Your Coverage Today

Waiting until you are at the pharmacy counter is the worst time to discover an exclusion. Here is a concrete sequence:

Step 1: Check the BCBSIL Online Drug Formulary

Log into your member account at bcbsil.com and manage to "Prescription Benefits" or "Drug List." Search for "sildenafil" and note the tier and any PA requirements listed. If you see a lock icon or "PA required," proceed to Step 2.

Step 2: Call Pharmacy Benefits Member Services

The number on the back of your card labeled "Rx" or "Pharmacy Benefits" connects you to the benefits team. Ask: "Is sildenafil 100 mg covered under my plan? What tier? Is prior authorization required? What are the PA criteria?"

Step 3: Ask Your Physician to Submit PA on Your Behalf

Most physician offices have an in-house PA coordinator or use an electronic PA tool such as CoverMyMeds. The PA submission for sildenafil is typically straightforward when your chart contains a documented ED diagnosis, a note that nitrates are contraindicated or absent from your medication list, and a recent cardiovascular risk assessment.

Step 4: Compare GoodRx or Manufacturer Coupons Against Your Copay

Even if your plan covers sildenafil with a $30 copay, GoodRx or similar discount programs sometimes beat insurance for generic sildenafil. You cannot use both simultaneously, but you can choose whichever is cheaper at point of sale. Pfizer's RxPathways program offers cost assistance for brand Viagra to eligible patients [12].

Cardiovascular Considerations Your Prescriber Will Evaluate

Sildenafil is not appropriate for every patient. The FDA prescribing information for sildenafil carries a contraindication for concurrent use with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) in any form because the combination can cause severe hypotension [3]. Patients on alpha-blockers require dose adjustments. The Princeton III Consensus Conference (2012) stratified sexual activity risk in cardiovascular patients and remains the most-cited clinical framework for this assessment [13].

Men with uncontrolled hypertension (systolic blood pressure above 170 mmHg), unstable angina, recent myocardial infarction within 90 days, or advanced heart failure (NYHA Class IV) should not receive sildenafil until their cardiovascular status is stabilized.

The FDA's 2014 Drug Safety Communication on PDE5 inhibitors emphasized that prescribers must assess baseline blood pressure before initiating therapy [3].

A Note on Testosterone Deficiency and ED

Erectile dysfunction in men over 40 is frequently associated with low testosterone. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "We recommend measuring morning total testosterone in men with symptoms and signs suggestive of testosterone deficiency" [14]. If low testosterone is contributing to ED, treating the hormonal deficit may improve response to sildenafil or may reduce the dose required.

BCBSIL covers testosterone replacement therapy under different formulary rules than sildenafil. A complete hormonal workup that includes total testosterone, free testosterone, LH, FSH, and prolactin can help clarify whether ED is purely vascular, neurogenic, or partly hormonal in origin.